OCEANIC-AF
Multicenter, randomized, active comparator-controlled, double-blind, double-dummy, parallel group phase III study of the oral FXIa inhibitor BAY 2433334 for the prevention of stroke or systemic embolism in patients with atrial fibrillation
- Stage
- klaar
- Medicine
- FXIa inhibitor BAY 2433334
- Population
- Ritme
- Phase
- III
- First Patient In
- 16 January 2023
- Last Patient In
- 20 November 2023
- Last Patient Last Visit
- 15 December 2023
National Lead
dr. M.E.W. Hemels
Cardioloog
Office Contact
